China aims to produce 1 billion doses of the Covid-19 vaccine a year

A Chinese health department official said Friday that the country's annual production capacity for the coronavirus vaccine will increase by 1 billion doses next year, following the government's aggressive cooperation program to build new factories.

China aims to produce 1 billion doses of the Covid-19 vaccine a year

The capacity is expected’ to reach 610 million doses by the end of this year, said Zheng Zhongwei of the National Health Commission.

"Next year, our annual capacity will reach more than 1 billion doses," he told a news conference.

American pharmaceutical giants Pfizer and Moderna also aim to produce one billion doses by 2021.

Zheng said the distribution of vaccines would give priority to groups such as medical workers, border guards and the elderly before they become available to the general public.

China has promoted the construction of vaccine testing facilities and manufacturing plants, and has set up independent monitors for its assembly. There are 11 candidates for the vaccine in human trials in China, four of whom are currently in the third and final trials.

One of them is Corona Week, made by the private company Sinovac, which is already sliding on the factory floor in a geo-safe facility outside Beijing. Yin Weidong, chairman of Sino week, said Thursday that the factory had been built’ for months, and more could be built if demand was high.

Some countries are working on vaccines to ensure success against the disease. Under the World Health Organization, more than 150 countries are establishing the COVID-19 vaccine Global Access Facility, or COVAX.

Their goal is to create 2 billion doses to vaccinate 20% of the world's population.

The WHO Director-General, Tedros Ghebreyesus said earlier this month that "the goal is to vaccinate some people in all countries, not just in some countries."


Kim Jong Un apologized for the deadly South Korean shooting